Zimbabwe has declined a significant American health deal valued at $367m (£272m) over five years due to Washington's demand for sensitive data.
The decision was revealed following a government memo dated December was leaked, which showed Head of State Emmerson Mnangagwa deemed the deal was "lopsided".
A government spokesman later clarified that the United States was seeking health data for scientific study and commercial gain but was not willing to share the benefits from any future vaccines.
"We are forced to start the difficult and regrettable task of scaling back our support in Zimbabwe," said American envoy to Zimbabwe Pamela Tremont publicly.
The US Embassy said the United States had provided over $1.9bn for health programmes to Zimbabwe over the last two decades.
A medical body in Zimbabwe has called for further dialogue to find a deal suitable to both sides so the country's vital HIV programme can proceed.
Wider Context
This rejection follows a comparable case in Kenya, where a high court blocked a related health funding agreement after legal challenges were raised about the security of citizens' health data.
Since returning to the presidency recently, US President Donald Trump has drastically cut overseas assistance and closed the US Agency for International Development (USAID).
USAID had overseen assistance for the American government, but Trump stated its expenditure was "wasteful" and his government was pursuing direct bilateral deals to enhance transparency and accountability.
According to reports, 16 nations in Africa have to date agreed to similar health pacts, constituting more than $18.3bn in new funding.
Details of the Declined Deal
This assistance for Zimbabwe was intended to funded "combating HIV/Aids, TB, malaria, maternal and child health, and disease outbreak preparedness.
"We are confident this cooperation would have delivered significant advantages for Zimbabwean communities, particularly the 1.2 million currently on antiretroviral therapy through US-supported programmes," Tremont commented.
However, government spokesperson Nick Mangwana maintained the arrangement was "asymmetrical".
"The proposal required Zimbabwe to surrender its biological resources and data for a long time, without any corresponding guarantee of access to any scientific breakthroughs – like vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.
"In essence, our country would provide the basic resources for medical research with no assurance that the final treatments would be accessible to our people should a future health crisis emerge."
Sovereignty and International Frameworks
Mangwana further said that the US's withdrawal from the World Health Organization (WHO) and its push of bilateral deals were upending systems previously set up through the global health agency.
Mangwana gave as an example its Pandemic Benefit-Sharing scheme designed to deal with potential pandemics.
"This mechanism is designed to ensure that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not monopolised solely by those with the resources to develop them."
Zimbabwe's reservations over the US deal "are not meant as opposition to America," he added.
"We are open to continued discussions with our American counterparts on how future collaboration might be designed in a way that honours the sovereignty and dignity of each country."
Medical Community Reaction
A leading public health body stated it acknowledged the government's concerns, but recommended that talks should continue given that much of the nation's HIV programmes relied on external financing.
"Where specific concerns arise, including those relating to information security or agreement terms, these can often be resolved via detailed discussion and mutually agreed protections," the group added.
The situation emphasises the continuing challenges between accepting vital foreign assistance and safeguarding local interests in an increasingly data-driven world.